MNDJF Stock UPDATES Mandalay Res Corp (MNDJF) 1.0800 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2014 at 4:37 PM

Mandalay Res Corp (MNDJF) 1.0800 $MNDJF

Mandalay Resources Corporation Provides Notice of Second Quarter 2014 Financial Results and Conference Call
PR Newswire Europe - Fri Aug 01, 3:43PM CDT
TORONTO, August 1, 2014 /PRNewswire/ --

Mandalay Advances Bridge Loan to Elgin Mining
PR Newswire Europe - Thu Jul 31, 1:02PM CDT
TORONTO and VANCOUVER, British Columbia, July 31, 2014 /PRNewswire/ --

Elgin Mining Announces Drawdown on Previously Announced Bridge Loan with Mandalay Resources Corporation
Marketwire - Thu Jul 31, 12:57PM CDT
Elgin Mining Inc. ("Elgin Mining" or the "Company"

(TSX: ELG) announced today that is has received, by way of the previously disclosed convertible bridge loan, approximately C$5 million from Mandalay Resources Corporation ("Mandalay"

(TSX: MND).

Mandalay Resources Provides Update on Elgin Mining Transaction and Enters into Amended and Restated Arrangement Agreement
PR Newswire Europe - Fri Jul 25, 5:11PM CDT
TORONTO, July 25, 2014 /PRNewswire/ --

Elgin Mining Provides Update and Enters into Amended and Restated Arrangement Agreement with Mandalay Resources
Marketwire - Fri Jul 25, 4:30PM CDT
Elgin Mining Inc. ("Elgin Mining" or the "Company"

(TSX: ELG) is pleased to provide the following update on the previously announced transaction with Mandalay Resources Corporation ("Mandalay"

(TSX: MND). Elgin Mining has now reached a resolution on all outstanding reclamation obligations relating to its former coal operations in Kentucky, and these are to Mandalay's satisfaction. Elgin Mining has filed amended and restated interim financial statements and management's discussion and analysis for the three months ended March 31, 2014 to reflect this settlement. The parties have also entered into an amended and restated arrangement agreement ("Amended and Restated Arrangement Agreement"

dated July 25, 2014 with respect to the previously announced acquisition by Mandalay of all the outstanding common shares of Elgin Mining for consideration consisting of C$0.37 cash or 0.4111 of a Mandalay common share per Elgin Mining common share, subject to pro ration, by way of plan of arrangement (the "Arrangement"

.

Mandalay Resources Continues Infill and Extensional Drilling on N- and Cuffley Lodes at its Costerfield Gold-Antimony Mine, Victoria, Australia
PR Newswire Europe - Thu Jul 17, 6:36AM CDT
TORONTO, July 17, 2014 /PRNewswire/ --

Mandalay Resources Corporation Announces Production and Sales Results for the Second Quarter, 2014
PR Newswire Europe - Thu Jul 10, 6:31AM CDT
TORONTO, July 10, 2014 /PRNewswire/ --

Mandalay Resources Announces Multiple High-Grade Drill Intercepts on Several Veins and Begins Infill Drilling at its Cerro Bayo Silver-Gold Mine, Chile
PR Newswire Europe - Wed Jul 09, 3:58PM CDT
TORONTO, July 9, 2014 /PRNewswire/ --

Mandalay Resources Comments on Independent Report on Antimony Exposure in Costerfield, Australia
PR Newswire Europe - Mon Jun 30, 3:58PM CDT
TORONTO, June 30, 2014 /PRNewswire/ --

DNA Precious Metals Inc. Announces Coverage On The Gold Report
PR Newswire - Thu Jun 12, 7:30AM CDT
DNA Precious Metals, Inc. (OTCQB: DNAP) a near-term gold and silver producer through its Montauban mine property, located in Quebec, Canada, today announced that the Company is now featured on The Gold Report (http://www.theaureport.com) which will be publishing expert 3rd party commentary, research, and news regarding the developments and business strategy of the Company. This featured information may be viewed at the following link:http://www.theaureport.com/pub/co/6052

Mandalay Resources to Acquire Elgin Mining
PR Newswire Europe - Wed Jun 11, 6:25AM CDT
VANCOUVER, British Columbia and TORONTO, June 4, 2014 /PRNewswire/ --

Mandalay Resources Corporation Completes 5.875% Debt Financing
PR Newswire Europe - Tue Jun 10, 11:16PM CDT
TORONTO, May 14, 2014 /PRNewswire/ --

Mandalay Resources Corporation Announces Filing of Annual Information Form and Updated NI 43-101 Technical Reports for its Cerro Bayo and Costerfield Projects, Announces Annual General and Special Meeting Date
PR Newswire Europe - Fri Mar 28, 3:58PM CDT
TORONTO, March 28, 2014 /PRNewswire/ --

Mandalay Resources Corporation Announces Financial Results for the Fourth Quarter and Full Year 2013, and Quarterly Dividend
PR Newswire Europe - Tue Feb 18, 8:42PM CST
Mandalay Resources Corporation ("Mandalay" or the "Company"

announced today revenue of $39.1 million, EBITDA of $13.9 million and net income of $4.4 million or $0.01 per share for the fourth quarter of 2013. For the full year, the Company delivered revenue of $166.9 million, EBITDA of $67.7 million and net income of $29.4 million or $0.09 per share.

Mandalay Resources Corporation Increases Gold Reserves by 41% and Antimony Reserves by 108% in 2013
PR Newswire Europe - Thu Feb 13, 7:59AM CST
TORONTO, February 13, 2014 /PRNewswire/ --

Silver Standard Completes Sale of Challacollo Project
PR Newswire - Fri Feb 07, 2:00PM CST
Silver Standard Resources Inc. (NASDAQ: SSRI) (TSX: SSO) ("Silver Standard"

announces today that it has completed the sale of its Challacollo project in Region I, Chile to Mandalay Resources Corporation (TSX: MND) ("Mandalay"

for aggregate consideration at closing of $7.5 million in cash and 12 million common shares of Mandalay. This transaction was previously announced in Silver Standard's press release dated December 20, 2013.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...